This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carniel, E. Articles by Mestroni, L. Search for Related Content PubMed PubMed Citation Articles by Carniel, E. Articles by Mestroni, L. Related Collections Clinical genetics Myocardial cardiomyopathy disease Genetics of cardiovascular disease

(Circulation. 2005;112:54-59.)
© 2005 American Heart Association, Inc.

Heart Failure

-Myosin Heavy Chain

A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy

Elisa Carniel, MD; Matthew R.G. Taylor, MD, PhD; Gianfranco Sinagra, MD; Andrea Di Lenarda, MD; Lisa Ku, MS; Pamela R. Fain, PhD; Mark M. Boucek, MD; Jean Cavanaugh, MS; Snjezana Miocic, MD; Dobromir Slavov, PhD; Sharon L. Graw, PhD; Jennie Feiger, MS, MA; Xiao Zhong Zhu, BS; Dmi Dao, BA; Debra A. Ferguson, MS; Michael R. Bristow, MD, PhD; Luisa Mestroni, MD

From the Familial Cardiomyopathy Registry Research Group.

Reprint requests to Dr Luisa Mestroni, University of Colorado Cardiovascular Institute, Bioscience Park Center, 12635 E Montview Blvd, Suite 150, Aurora, CO 80010-7116. E-mail Luisa.Mestroni{at}UCHSC.edu

Received January 30, 2004; de novo received September 17, 2004; revision received February 24, 2005; accepted March 2, 2005.

Background— Mutations in the ß-myosin heavy-chain (ßMyHC) gene cause hypertrophic (HCM) and dilated (DCM) forms of cardiomyopathy. In failing human hearts, downregulation of MyHC mRNA or protein has been correlated with systolic dysfunction. We hypothesized that mutations in MyHC could also lead to pleiotropic cardiac phenotypes, including HCM and DCM.

Methods and Results— A cohort of 434 subjects, 374 (134 affected, 214 unaffected, 26 unknown) belonging to 69 DCM families and 60 (29 affected, 30 unaffected, 1 unknown) in 21 HCM families, was screened for MyHC gene (MYH6) mutations. Three heterozygous MYH6 missense mutations were identified in DCM probands (P830L, A1004S, and E1457K; 4.3% of probands). A Q1065H mutation was detected in 1 of 21 HCM probands and was absent in 2 unaffected offspring. All MYH6 mutations were distributed in highly conserved residues, were predicted to change the structure or chemical bonds of MyHC, and were absent in at least 300 control chromosomes from an ethnically similar population. The DCM carrier phenotype was characterized by late onset, whereas the HCM phenotype was characterized by progression toward dilation, left ventricular dysfunction, and refractory heart failure.

Conclusions— This study suggests that mutations in MYH6 may cause a spectrum of phenotypes ranging from DCM to HCM.

Key Words: genetics • myosin • cardiomyopathy, hypertrophic • cardiomyopathy, dilated

This article has been cited by other articles:

				J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]

				J. D. Franke, R. A. Montague, W. L. Rickoll, and D. P. Kiehart An MYH9 human disease model in flies: site-directed mutagenesis of the Drosophila non-muscle myosin II results in hypomorphic alleles with dominant character Hum. Mol. Genet., December 15, 2007; 16(24): 3160 - 3173. [Abstract] [Full Text] [PDF]